NIFTY 50▼24,406.10
-7.40 (-0.03%)
SENSEX▼80,039.80
-109.08 (-0.14%)
NIFTY BANK▼50,888.75
-428.25 (-0.83%)
INDIAN RAILWAY FINANCE CORP▼183.56
-8.71 (-4.53%)
TATA MOTORS▲1,090.95
63.25 (6.15%)
TATA STEEL▼157.39
-2.92 (-1.82%)
TATA POWER▲423.35
3.40 (0.81%)
SUZLON ENERGY▲61.47
0.75 (1.24%)
RAIL VIKAS NIGAM▼575.70
-18.05 (-3.04%)
INDIAN RENEWABLE ENERGY▼261.18
-8.08 (-3.00%)
VODAFONE IDEA▼15.18
-0.40 (-2.57%)
RELIANCE INDUSTRIES▼2,984.80
-6.60 (-0.22%)
YES BANK▼24.62
-0.28 (-1.12%)
ADANI POWER▲695.20
0.50 (0.07%)
NHPC▼101.96
-0.42 (-0.41%)
STATE BANK OF INDIA▼848.50
-3.50 (-0.41%)
HDFC BANK▲1,616.60
12.55 (0.78%)
RELIANCE POWER▲29.69
1.41 (4.99%)
JIO FIN SERVICES LTD▼329.20
-5.50 (-1.64%)
ZOMATO▼219.31
-4.18 (-1.87%)
ADANI PORT & SEZ▲1,487.00
2.20 (0.15%)
BHARAT ELECTRONICS▲301.45
1.35 (0.45%)
INDIAN RAILWAY TOURISM CORP▼969.15
-5.05 (-0.52%)
INDIAN OIL CORP▲176.85
8.06 (4.78%)
RATTANINDIA POWER▲16.81
0.80 (5.00%)
MRF▲1,37,590.10
317.45 (0.23%)
ADANI ENTERPRISES▲2,973.50
2.80 (0.09%)
JAIPRAKASH POWER VENTURES▲18.83
0.03 (0.16%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/BSE_EQ|INE773D01018.png)
TRANSGENE BIOTEK LTD Share Price
TRABI
₹9.87+₹0.05 (0.51%) TodayLast updated on 25 Jul, 2024 | 15:29 IST
₹9.41₹10.05
L
H
What’s in news?
Company overview
Financial performance
Market cap
| Open₹10.05 | Close₹9.82 |
Circuit range₹10.31 - ₹9.33 | Day range₹9.41 - ₹10.05 | Year range₹3.62 - ₹12.46 |
Volume35,637 | Avg. traded₹9.65 | Revenue (12m)₹0 Crs |
TRANSGENE BIOTEK LTDTransgene Biotek Limited is an India-based biotechnology company. The Company is engaged in the research and development of vaccines, oncology and new drug delivery technologies. Its portfolio of products includes oncology, auto-immunity, drug delivery and biogenerics. The Company offers TrabiAAV, which is a platform for the delivery of micro ribonucleic acids (miRNAs), short hairpin RNA (ShRNAs), immunogens developing clinical significance in gene therapy and CRISPR/cas 9 technologies. Its monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells. Its TrabiORAL is focused on delivering proteins and peptides orally for a variety of human diseases. Its TBL-1203, is used to strengthen cell-mediated immunity and complete elimination of the human immunodeficiency virus (HIV), without any need for retroviral drug therapy. Its Tacrolimus is a drug that suppresses the immune system and is mainly used to prevent rejection of transplanted organs.
TRANSGENE BIOTEK LTD Key indicators
52 week high₹12.46 | 52 week low₹3.62 | P/E ratio |
P/B ratio7.08 | ROE-- | ROCE-57.49% |
Dividend yield-- | Debt/Equity ratio-2.11 | EPS-0.79 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin-789.22% | Net profit margin0% |
ROE0% | ROA-17.24% |
ROCE-57.49% |
Learn more
TRANSGENE BIOTEK LTD Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Wed, Jul 24 2024 | ₹10.03 | ₹9.82 | |
Tue, Jul 23 2024 | ₹9.99 | ₹9.56 | -0.10% |
Mon, Jul 22 2024 | ₹10.20 | ₹9.57 | -1.54% |
Fri, Jul 19 2024 | ₹10.09 | ₹9.72 | -2.80% |
Thu, Jul 18 2024 | ₹10.11 | ₹10.00 | -0.79% |
Tue, Jul 16 2024 | ₹10.48 | ₹10.08 | -0.20% |
Mon, Jul 15 2024 | ₹10.55 | ₹10.10 | -2.42% |
Fri, Jul 12 2024 | ₹10.00 | ₹10.35 |